2014 Hemostasis Gordon Research Conference and Gordon Research Seminar

描述（由申请人提供）： 我们请求对止血戈登研究研讨会（GRS）和戈登研究会议（GRC）提供部分支持，该研讨会将于2014年7月26日至8月1日在新罕布什尔州沃特维尔谷的GRC研究中心举行。GRC止血会议始于1973年，此后每两年举行一次。2014年会议是该系列会议的第32次会议，被认为是止血研究的首次会议。在2014年止血GRC会议之前，将举行一次专门讨论学员发展和暴露的GRS会议。GRS会议由受训人员组织和管理，非常成功，并提高了学员在GRC的形象。止血GRS/GRC汇集了对血小板和凝血蛋白的生物学，生物化学和遗传学感兴趣的科学家，参与出血和血栓性疾病治疗的医生以及来自小型和大型制药公司的研究人员，开发止血疾病的新疗法。该会议具有传奇般的地位，使其成为展示前沿研究和揭示该领域重大进展的论坛。事实上，止血领域最近取得的一些最引人注目的成就在本系列的前几次会议上首次亮相，或者是由本次会议促进的合作互动推动的。受邀发言者和同意参加全球研究报告和全球研究报告的讨论领导人名单令人印象深刻，代表了该领域的顶级研究人员。这些演讲者和讨论领导者将为所有与会者，特别是初级与会者， 调查员和学员。2014年止血GRS和GRC计划包括妇女，少数民族和年轻研究者的参与程度高于以往的会议。此外，2014年的会议将包括大量的与会者谁是初级教师，学生，博士后研究员和身体残疾的个人。2014年 止血GRS计划包括Jane Freedman博士（一位非常成功的女医生-科学家）的主题演讲、学员的12次演讲和40次海报讨论。2014年止血GRC计划将有4个海报聚会和8个演讲会，包括：1。血栓形成和凝血中的血管壁; 2.感染期间的血栓形成和凝血; 3.发育和疾病中的血小板和凝血因子; 4。血管环境中的串扰; 5.血栓形成、凝血和炎症之间的联系; 6.凝血和血小板减少症; 7.热门主题摘要会谈，其中8名学员介绍他们的工作;和，8。止血缺陷。会议将于8月1日晚结束，主题为“小鼠和人类遗传学对血栓形成和止血的影响”。

DESCRIPTION (provided by applicant): We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC), which will be held at the GRC site in Waterville Valley, NH, July 26th through August 1st, 2014. The GRC meeting on hemostasis began in 1973 and has been held biennially since then. The 2014 conference represents the 32nd meeting in the series and is considered the premiere meeting for hemostasis-based research. The 2014 Hemostasis GRC meeting will be preceded by a GRS meeting dedicated to trainee development and exposure. The GRS meeting is organized and run by trainees, is highly successful, and enhances the profile of trainees at the GRC. The Hemostasis GRS/GRC brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have agreed to participate in the GRS and GRC is impressive and represents top investigators in the field. These speakers and discussion leaders will enhance the stimulating nature of the environment for all attendees, especially junior investigators and trainees. The 2014 Hemostasis GRS and GRC programs include heightened participation from women, minorities, and young investigators compared to previous conferences. Moreover, the 2014 meeting will include a significant number of attendees who are junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The 2014 Hemostasis GRS program includes a keynote presentation from Dr. Jane Freedman, a very successful female physician-scientist, 12 presentations from trainees, and 40 poster discussions. The 2014 Hemostasis GRC program will have 4 poster gatherings and 8 presentation sessions that include: 1. The Vessel Wall in Thrombosis and Coagulation; 2. Thrombosis and Coagulation During Infection; 3. Platelets and Coagulation Factors in Development and Disease; 4. Crosstalk in the Vascular Milieu; 5. Links Between Thrombosis, Coagulation, and Inflammation; 6. Coagulation and Platelets in Disease; 7. Hot Topic Abstract Talks where 8 trainees present their work; and, 8. Defective Hemostasis. The conference will end on the evening of August 1st with a keynote session entitled "The Impact of Mouse and Human Genetics on Thrombosis and Hemostasis".